PublicationsDiatech Admin2018-12-12T10:54:12+01:00

Publications

Leader in the development, production and
commercialisation of pharmacogenetics tests
for cancer precision medicine.

110, 2016

Daniela Furlan et al., Detection of early genetic and epigenetic alterations in NSCLC by using mass spectrometry and pyrosequencing analysis. Annals of Oncology

2209, 2016

Andrea Botticelli et al., Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker? PLOS One

3108, 2016

Giuseppe Aprile et al., Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors. Future Oncology

3008, 2016

Giorgia Gurioli et al., Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach. Journal of Translational Medicine

3008, 2016

Lorenzo Gerratana et al., Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example. Onco Targets and Therapy

2108, 2016

Roberto Moretto et al., Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer. The Oncologist

707, 2016

Maria Rosaria Raspollini et al., Multiple and bilateral kidney tumors with clear cells of three different histotypes: A case report with clinicopathologic and molecular study. APMIS

707, 2016

Andrea Casadei Gardini et al., Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report. BMC Cancer

707, 2016

Rossella Bruno et al., Aberrant expression of anaplastic lymphoma kinase in lung adenocarcinoma: Analysis of circulating free tumor RNA using one-step reverse transcription-polymerase chain reaction. Molecular Medicine Reports

307, 2016

Filippo Martignano et al., GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications. Disease Markers

1406, 2016

Riccardo Giannini et al., EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center. Oncology Reports

306, 2016

Maria Rosaria Raspolini et al., Genetic mutations in accordance with a low malignant potential tumour are not demonstrated in clear cell papillary renal cell carcinoma. Journal of Clinical Pathology

Previous 232425 Next